Report safety data for Inupadenant and pembrolizumab in melanoma
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 11 Jan 2021
- Due
- 30 Jun 2021
- Checked
- 24 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Safety 2Q 2021”
What we found
Evidence strength A What the grades mean
The company reported monotherapy data in 2Q 2021, but filings indicate the combination trial with pembrolizumab in melanoma was still ongoing or in expansion phases well after the deadline.
-
A iTeos Therapeutics, Inc. 10-Q filed 2021-08-11
“In June 2021, we reported additional data from monotherapy expansion cohorts at the American Society of Clinical Oncology (ASCO) annual meeting.” ✓ confirmed on the page
-
A iTeos Therapeutics, Inc. 10-Q filed 2021-11-10
“We have also initiated an expansion arm evaluating inupadenant in combination with pembrolizumab in patients with PD-1-resistant melanoma.” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Inupadenant and pembrolizumab safety data
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Regulatory, Customer
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: disagreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and read it as “no_evidence”, so a person decides.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you iTeos Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C808865-021555 · Corrections policy